TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the ef...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Siva, Shankar, Chesson, Brent, Bressel, Mathias, Pryor, David, Higgs, Braden, Reynolds, Hayley M., Hardcastle, Nicholas, Montgomery, Rebecca, Vanneste, Ben, Khoo, Vincent, Ruben, Jeremy, Lau, Eddie, Hofman, Michael S., De Abreu Lourenco, Richard, Sridharan, Swetha, Brook, Nicholas R., Martin, Jarad, Lawrentschuk, Nathan, Kron, Tomas, Foroudi, Farshad
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199711/
https://ncbi.nlm.nih.gov/pubmed/30352550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4916-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki